After the successful completion of the Feasibility Study, Chemgineering International has been also awarded for the Extended Conceptual Design phase for a new high tech investment in the pharmaceutical industry in the South of Europe.

On a land plot of about 1,6ha, a new facility including production areas (biotech, sterile- and non-sterile, QC labs, warehouses and R&D areas) as well as all necessary supporting functions of in total 10.000m² will be constructed. After commissioning, the plant will produce various veterinary drugs.